Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: margaret foley who wrote (5580)	9/18/1998 3:08:00 AM
From: Uncle Frank	Respond to of 9523

Margaret, 3Q earnings are due out in early October. The analysts have held firm at .57 vs .47 last quarter, and .46 in 1997. You can check out the details at biz.yahoo.com. I'm surprised at the analyst's ratings; 19 of 33 rate pfe a hold. I think the Street feels pfe is appropriately valued, and wants to see strong earnings growth before they'll let it run again. The fourth quarter should be exciting, with all the new markets that have been opened recently, and 1999 will be outstanding (since I think the analysts have severely underestimated the earnings potential of Viagra). imho, Frank